CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 125 of 138 entries

View as:

A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

Phase: N/A Priority: Normal

NCT ID: NCT03399084 Org: User:

Start: 11/29/17 End: 01/15/19 Due: 01/15/20

Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Respiratory Tract Infections

Phase: N/A Priority: Normal

NCT ID: NCT05588804 Org: User:

Start: 11/07/22 End: 12/18/22 Due: 12/18/23

A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma

Phase: N/A Priority: Normal

NCT ID: NCT06153238 Org: User:

Start: 05/15/24 End: 07/31/26 Due: 07/31/27

Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.

Phase: N/A Priority: Normal

NCT ID: NCT03993288 Org: User:

Start: 06/27/19 End: 06/18/20 Due: 06/18/21

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00960310 Org: User:

Start: 06/30/06 End: 06/30/06 Due: 06/30/07

To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg

Phase: N/A Priority: Normal

NCT ID: NCT00947076 Org: User:

Start: 02/28/01 End: 04/30/01 Due: 04/30/02

A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00864981 Org: User:

Start: 09/30/05 End: 10/31/05 Due: 10/31/06

A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility

Phase: N/A Priority: Normal

NCT ID: NCT00002006 Org: User:

Start: - End: - Due: -

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00865618 Org: User:

Start: 06/30/06 End: 07/31/06 Due: 07/31/07

To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00881634 Org: User:

Start: 06/30/05 End: 07/31/05 Due: 07/31/06

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

Phase: N/A Priority: Normal

NCT ID: NCT05161806 Org: User:

Start: 03/11/22 End: 05/04/22 Due: 05/04/23

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal

NCT ID: NCT05887843 Org: User:

Start: 06/08/23 End: 09/08/23 Due: 09/08/24

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

Phase: N/A Priority: Normal

NCT ID: NCT00946608 Org: User:

Start: 06/30/05 End: 08/31/05 Due: 08/31/06

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00913887 Org: User:

Start: 04/30/94 End: 05/31/94 Due: 05/31/95

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Phase: N/A Priority: Normal

NCT ID: NCT06587451 Org: User:

Start: 12/19/24 End: 07/31/27 Due: 07/31/28

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

Phase: N/A Priority: Normal

NCT ID: NCT01891864 Org: User:

Start: 06/30/13 End: 03/31/15 Due: 03/31/16

Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00960245 Org: User:

Start: 07/31/94 End: 07/31/94 Due: 07/31/95

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00882700 Org: User:

Start: 04/30/05 End: 04/30/05 Due: 04/30/06

To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00946764 Org: User:

Start: 07/31/05 End: 09/30/05 Due: 09/30/06

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00881426 Org: User:

Start: 03/31/04 End: 04/30/04 Due: 04/30/05

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Phase: N/A Priority: Normal

NCT ID: NCT00946790 Org: User:

Start: 07/31/93 End: 12/31/93 Due: 12/31/94

To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00913588 Org: User:

Start: 05/31/96 End: 08/31/96 Due: 08/31/97

A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.

Phase: N/A Priority: Normal

NCT ID: NCT00002253 Org: User:

Start: - End: - Due: -

HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal

NCT ID: NCT01576341 Org: User:

Start: 04/30/12 End: 06/30/15 Due: 06/30/16

To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions

Phase: N/A Priority: Normal

NCT ID: NCT00881127 Org: User:

Start: 07/31/05 End: 07/31/05 Due: 07/31/06

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia	NCT03399084	Sandoz	user2@example.com	None	2017-11-29	2019-01-15	2020-01-15	-	-	2025-07-14
Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Respiratory Tract Infections	NCT05588804	Sandoz	user2@example.com	None	2022-11-07	2022-12-18	2023-12-18	-	-	2025-07-14
A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma	NCT06153238	Sandoz	user2@example.com	None	2024-05-15	2026-07-31	2027-07-31	-	-	2025-07-14
Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.	NCT03993288	Sandoz	user2@example.com	None	2019-06-27	2020-06-18	2021-06-18	-	-	2025-07-14
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions	NCT00960310	Sandoz	user2@example.com	None	2006-06-30	2006-06-30	2007-06-30	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg	NCT00947076	Sandoz	user2@example.com	None	2001-02-28	2001-04-30	2002-04-30	-	-	2025-07-14
A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions	NCT00864981	Sandoz	user2@example.com	None	2005-09-30	2005-10-31	2006-10-31	-	-	2025-07-14
A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility	NCT00002006	Sandoz	user2@example.com	None	-	-	-	-	-	2025-07-14
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions	NCT00865618	Sandoz	user2@example.com	None	2006-06-30	2006-07-31	2007-07-31	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions	NCT00881634	Sandoz	user2@example.com	None	2005-06-30	2005-07-31	2006-07-31	-	-	2025-07-14
Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe	NCT05161806	Sandoz	user2@example.com	None	2022-03-11	2022-05-04	2023-05-04	-	-	2025-07-14
Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis	NCT05887843	Sandoz	user2@example.com	None	2023-06-08	2023-09-08	2024-09-08	-	-	2025-07-14
To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets	NCT00946608	Sandoz	user2@example.com	None	2005-06-30	2005-08-31	2006-08-31	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions	NCT00913887	Sandoz	user2@example.com	None	1994-04-30	1994-05-31	1995-05-31	-	-	2025-07-14
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®	NCT06587451	Sandoz	user2@example.com	None	2024-12-19	2027-07-31	2028-07-31	-	-	2025-07-14
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel	NCT01891864	Sandoz	user2@example.com	None	2013-06-30	2015-03-31	2016-03-31	-	-	2025-07-14
Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions	NCT00960245	Sandoz	user2@example.com	None	1994-07-31	1994-07-31	1995-07-31	-	-	2025-07-14
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions	NCT00882700	Sandoz	user2@example.com	None	2005-04-30	2005-04-30	2006-04-30	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions	NCT00946764	Sandoz	user2@example.com	None	2005-07-31	2005-09-30	2006-09-30	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions	NCT00881426	Sandoz	user2@example.com	None	2004-03-31	2004-04-30	2005-04-30	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets	NCT00946790	Sandoz	user2@example.com	None	1993-07-31	1993-12-31	1994-12-31	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted Conditions	NCT00913588	Sandoz	user2@example.com	None	1996-05-31	1996-08-31	1997-08-31	-	-	2025-07-14
A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.	NCT00002253	Sandoz	user2@example.com	None	-	-	-	-	-	2025-07-14
HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)	NCT01576341	Sandoz	user2@example.com	None	2012-04-30	2015-06-30	2016-06-30	-	-	2025-07-14
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions	NCT00881127	Sandoz	user2@example.com	None	2005-07-31	2005-07-31	2006-07-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance